Suppression of lymphocyte mitogenesis by tamoxifen: studies on protein kinase C, calmodulin and calcium.

Neuroimmunomodulation

Department of Internal Medicine, the Manitoba Cancer Treatment and Research Foundation, Faculty of Medicine, University of Manitoba, Winnipeg, Manitoba, Canada.

Published: March 2000

AI Article Synopsis

Article Abstract

The effect of tamoxifen (TX; 1.0 microM) on the mitogenic response of rat lymphocytes was compared with the effect of drugs that are known to act on protein kinase C (PKC), calmodulin (CM), and calcium (Ca(2+)). The calcium ionophore A23187 (0.2 microM) was mitogenic on its own which was not influenced by TX. The agents modulating PKC or CM (phorbol-myristate-13-acetate; R24571, chlorpromazine) influenced mitogenesis differently than did TX. General inhibition of lymphocyte proliferation was seen with the Ca(2+) antagonist agents (EGTA, TMB-8) as with TX. The antiproliferative effect of TX was partially reversed by the increase of Ca(2+) in the culture medium when T cell mitogens were used, but not in the case of lipid A, a B lymphocyte mitogen. However, the concanavalin A-induced Ca(2+) influx was further elevated by TX which differed from the effect of the Ca(2+) channel-blocking agent verapamil. The results suggest that TX resets the threshold stimulus necessary for mitogenesis and is completely reversible.

Download full-text PDF

Source
http://dx.doi.org/10.1159/000026422DOI Listing

Publication Analysis

Top Keywords

protein kinase
8
calmodulin calcium
8
microm mitogenic
8
ca2+
5
suppression lymphocyte
4
lymphocyte mitogenesis
4
mitogenesis tamoxifen
4
tamoxifen studies
4
studies protein
4
kinase calmodulin
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!